Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder (TA292)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 July 2013
Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal) (TA286)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 May 2013
Guidance on the use of electroconvulsive therapy (TA59)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 October 2009Published: 26 April 2003